Inverness international expansion effort continues
This article was originally published in The Gray Sheet
Executive Summary
Inverness continues to expand its international presence by acquiring Australian diagnostics firm Panbio for $37 million, the firm announces Oct. 8. Panbio makes tests for flaviviruses and other arthropod-borne viruses. "Panbio's position in the dengue fever diagnostic market will help Inverness [respond] to the recent spread of the disease throughout South America and elsewhere," Inverness explains. The move comes just days after Inverness' purchase of UK diagnostics distributor Bio-Stat for $33.4 million (1"The Gray Sheet" Oct. 8, 2007, In Brief)